Study in Subjects Greater Than 40 Years of Age With COPD
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, Phase IIIb, randomized, double-blind, active-controlled,
parallel-group, comparative study.
The objectives of this study are:
1. To compare the efficacy of tiotropium 18 mcg once daily plus Formoterol Fumarate
Inhalation Solution (FFIS) 20 mcg twice daily to tiotropium 18 mcg once daily.
2. To obtain safety data on the use of tiotropium 18 mcg once daily plus FFIS 20 mcg twice
daily compared to tiotropium 18 mcg once daily.